Literature DB >> 19491248

The role of the intestinal microbiota in enteric infection.

Inna Sekirov1, B Brett Finlay.   

Abstract

The consortia of microorganisms inhabiting the length of the gastrointestinal tract, the gastrointestinal microbiota, are vital to many aspects of normal host physiology. In addition, they are an active participant in the progression of many diseases, among them enteric infections. Healthy intestinal microbiota contribute to host resistance to infection through their involvement in the development of the host immune system and provision of colonization resistance. It is not surprising then that disruptions of the microbial community translate into alterations of host susceptibility to infection. Additionally, the process of the infection itself results in a disturbance to the microbiota. This disturbance is often mediated by the host inflammatory response, allowing the pathogen to benefit from the inflammation at the intestinal mucosa. Uncovering the mechanisms underlying the host-pathogen-microbiota interactions will facilitate our understanding of the infection process and promote design of more effective and focused prophylactic and therapeutic strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19491248      PMCID: PMC2754356          DOI: 10.1113/jphysiol.2009.172742

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  52 in total

Review 1.  Anatomical basis of tolerance and immunity to intestinal antigens.

Authors:  Allan McI Mowat
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

2.  Interactions between commensal intestinal bacteria and the immune system.

Authors:  Andrew J Macpherson; Nicola L Harris
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

3.  Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells.

Authors:  Hanne R Christensen; Hanne Frøkiaer; James J Pestka
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

4.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane.

Authors:  H L Alakomi; E Skyttä; M Saarela; T Mattila-Sandholm; K Latva-Kala; I M Helander
Journal:  Appl Environ Microbiol       Date:  2000-05       Impact factor: 4.792

6.  Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection.

Authors:  Amy Croswell; Elad Amir; Paul Teggatz; Melissa Barman; Nita H Salzman
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

7.  Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut.

Authors:  Keiichiro Suzuki; Bob Meek; Yasuko Doi; Masamichi Muramatsu; Tsutomu Chiba; Tasuku Honjo; Sidonia Fagarasan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

8.  Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways.

Authors:  J Schauber; C Svanholm; S Termén; K Iffland; T Menzel; W Scheppach; R Melcher; B Agerberth; H Lührs; G H Gudmundsson
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

9.  Angiogenins: a new class of microbicidal proteins involved in innate immunity.

Authors:  Lora V Hooper; Thaddeus S Stappenbeck; Chieu V Hong; Jeffrey I Gordon
Journal:  Nat Immunol       Date:  2003-01-27       Impact factor: 25.606

10.  Honor thy symbionts.

Authors:  Jian Xu; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-15       Impact factor: 11.205

View more
  74 in total

1.  QseC Signaling in the Outbreak O104:H4 Escherichia coli Strain Combines Multiple Factors during Infection.

Authors:  Tamara Renata Machado Ribeiro; Bruna Cardinali Lustri; Waldir P Elias; Cristiano Gallina Moreira
Journal:  J Bacteriol       Date:  2019-08-08       Impact factor: 3.490

2.  Effect of antibiotic treatment on the intestinal metabolome.

Authors:  L Caetano M Antunes; Jun Han; Rosana B R Ferreira; Petra Lolić; Christoph H Borchers; B Brett Finlay
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

Review 3.  Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.

Authors:  E G Pamer
Journal:  Mucosal Immunol       Date:  2014-01-08       Impact factor: 7.313

4.  Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes.

Authors:  Chiara Sorini; Marika Falcone
Journal:  Am J Clin Exp Immunol       Date:  2013-06-15

5.  The world within--impact of the intestinal micobiota on whole body physiology and pathophysiology.

Authors:  Kim E Barrett
Journal:  J Physiol       Date:  2009-09-01       Impact factor: 5.182

Review 6.  Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis.

Authors:  Charles L Bevins; Nita H Salzman
Journal:  Nat Rev Microbiol       Date:  2011-03-22       Impact factor: 60.633

Review 7.  The Burden of Enteropathy and "Subclinical" Infections.

Authors:  Elizabeth T Rogawski; Richard L Guerrant
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

Review 8.  Genetic and Environmental Contributors for Celiac Disease.

Authors:  Gloria Serena; Rosiane Lima; Alessio Fasano
Journal:  Curr Allergy Asthma Rep       Date:  2019-07-18       Impact factor: 4.806

9.  Culturable gut microbiota diversity in zebrafish.

Authors:  Leon Cantas; Jan Roger Torp Sørby; Peter Aleström; Henning Sørum
Journal:  Zebrafish       Date:  2012-03       Impact factor: 1.985

Review 10.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.